Laboratoires Pierre Fabre is a French multinational

pharmaceutical A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field an ...

and cosmetics company. The company had a consolidated turnover of 1.978 billion euros in 2012 (including 54% international). It is headquartered in the city of

Castres Castres (; ''Castras'' in the Languedocian dialect of Occitan) is the sole subprefecture of the Tarn department in the Occitanie region in Southern France. It lies in the former province of Languedoc, although not in the former region of Lan ...

Midi-Pyrénées Midi-Pyrénées (; oc, Miègjorn-Pirenèus or ; es, Mediodía-Pirineos) is a former administrative region of France. Since 1 January 2016, it has been part of the new region of Occitania. It was the largest region of Metropolitan France by ar ...

, France. Founded in 1962 by Pierre Fabre (1926-2013), the company is present in over 130 countries. Laboratories Pierre Fabre had approximately 10,000 employees in 2012, 33% of whom are internationally based, while the remaining 6,700 employees were based in France. The company's business activity is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products. Pharmaceuticals and

phytotherapy Herbal medicine (also herbalism) is the study of pharmacognosy and the use of medicinal plants, which are a basis of traditional medicine. With worldwide research into pharmacology, some herbal medicines have been translated into modern remed ...

represent 47% of turnover, whereas cosmetics represent 53% (percentages of 2012 turnover). Pierre Fabre is best known for its

vinorelbine Vinorelbine (NVB), sold under the brand name Navelbine among others, is a chemotherapy medication used to treat a number of types of cancer. This includes breast cancer and non-small cell lung cancer. It is given by injection into a vein or by mou ...

(Navelbine), an anticancer drug of the ''vinca'' alkaloid class. They also developed vinflunine, a fluorinated ''vinca'' alkaloid derivative available in Australia for "advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum containing regimen." Olivier Bohuon was Chief Executive from September 2010 to April 2011.

The Pierre Fabre Foundation

The Pierre Fabre Foundation was recognized as a public utility in 1999 and its mission is to enable communities from less advanced and emerging countries, as well as those plunged into severe crisis by political or economic upheaval and/or natural disaster, to access the quality and levels of everyday health care and the widely-used drugs defined by the WHO and other organisations as essential to human health.

References

External links

*
Pierre Fabre laboratories
- Official site Pharmaceutical companies of France Pharmaceutical companies established in 1962 Companies based in Paris French brands {{med-company-stub